Laurent Veron

Title: Innovations by Laurent Veron in Gene Therapy

Introduction

Laurent Veron is a notable inventor based in Lyon, France. He has made significant contributions to the field of gene therapy through his innovative work on cationic polymers. His research focuses on the development of novel compounds that can facilitate the transfer of nucleic acids into target cells, which is crucial for effective gene therapy.

Latest Patents

Laurent Veron holds a patent for "Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy." This invention involves cationic polymers characterized by specific formulas that enhance their effectiveness in gene therapy applications. The patent outlines the structure of these polymers, emphasizing the importance of hydrophilic groups and free NH functions in their design. This innovation is particularly useful for transferring nucleic acids into target cells, thereby advancing the field of gene therapy.

Career Highlights

Laurent Veron is associated with Transgene S.A., a company that specializes in developing innovative immunotherapies for cancer and infectious diseases. His work at Transgene has allowed him to contribute to groundbreaking research in the field of gene therapy, focusing on the practical applications of his patented technologies.

Collaborations

Laurent has collaborated with notable colleagues such as Hanno V J Kolbe and Otmane Boussif. These collaborations have further enriched his research and development efforts, leading to advancements in therapeutic applications.

Conclusion

Laurent Veron's contributions to the field of gene therapy through his innovative patents and collaborations highlight his role as a significant inventor in this area. His work continues to pave the way for new therapeutic strategies that can improve patient outcomes.